Riley Antony A — SEC insider filings

SEC reporting owner CIK 1339375. 25 insider filings on record with FilingPulse; latest filed 2026-08-27.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2021-04-13 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Forte Biosciences, Inc. (FBRX)CHIEF FINANCIAL OFFICER252 legs · 32,194 sh · $379,8312 legs · 25,000 sh · $106,10563

Insider filings — Riley Antony A

FiledFormIssuerReported transactionsSource
2026-08-274Forte Biosciences, Inc. (FBRX)Code (U): 42,600 · Disposition to issuer (D): 421 (derivative) · Disposition to issuer (D): 2,999 (derivative) · Disposition to issuer (D): 1,700 (derivative) · Disposition to issuer (D): 2,999 (derivative) · Disposition to issuer (D): 14,000 (derivative) · +6 moreEDGAR
2026-07-064Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 · Tax withholding (F): 134 @ $21.32 · Option exercise (M): 375 (derivative) @ $0EDGAR
2026-06-174Forte Biosciences, Inc. (FBRX)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2026-04-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 · Tax withholding (F): 134 @ $24.86 · Option exercise (M): 375 (derivative) @ $0EDGAR
2026-01-134Forte Biosciences, Inc. (FBRX)Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-01-024Forte Biosciences, Inc. (FBRX)Purchase (P): 9,680 @ $26.33 · Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $27.27 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-10-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 @ $0 · Tax withholding (F): 134 @ $14.52 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-07-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 @ $0 · Tax withholding (F): 134 @ $12.44 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-04-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $7.43 · Option exercise (M): 375 (derivative) @ $0EDGAR
2025-03-214Forte Biosciences, Inc. (FBRX)Grant/award (A): 323,000 (derivative) @ $0EDGAR
2025-01-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $22.71 · Option exercise (M): 375 (derivative) @ $0EDGAR
2024-11-224Forte Biosciences, Inc. (FBRX)Purchase (P): 22,514 @ $5.55EDGAR
2024-10-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 375 @ $0 · Tax withholding (F): 133 @ $5.16 · Option exercise (M): 375 (derivative) @ $0EDGAR
2024-07-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 9,375 @ $0 · Tax withholding (F): 3,345 @ $0.55 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2024-04-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 9,375 @ $0 · Tax withholding (F): 3,345 @ $0.71 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2024-03-254Forte Biosciences, Inc. (FBRX)Grant/award (A): 350,000 (derivative) @ $0EDGAR
2024-01-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 9,375 @ $0 · Tax withholding (F): 3,841 @ $0.82 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2023-10-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 9,375 @ $0 · Tax withholding (F): 3,241 @ $0.66 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2023-08-024Forte Biosciences, Inc. (FBRX)Grant/award (A): 148,514 @ $1.01EDGAR
2023-07-054Forte Biosciences, Inc. (FBRX)Option exercise (M): 9,375 @ $0 · Tax withholding (F): 3,241 @ $1.04 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2023-04-044Forte Biosciences, Inc. (FBRX)Option exercise (M): 9,375 @ $0 · Tax withholding (F): 3,241 @ $1.01 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2023-02-274Forte Biosciences, Inc. (FBRX)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2022-01-184Forte Biosciences, Inc. (FBRX)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2021-09-074Forte Biosciences, Inc. (FBRX)Sale (S): 21,484 @ $4.24 · Sale (S): 3,516 @ $4.27EDGAR
2021-04-134Forte Biosciences, Inc. (FBRX)Grant/award (A): 42,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1339375 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs